Education
About Us
Working with TipRanks
Follow Us
BioView Ltd. (IL:BIOV)
:BIOV
Total Valuation
Bio View has a market cap or net worth of 26.55M. The enterprise value is ―.
Market Cap26.55M
Enterprise Value―
Share Statistics
Bio View has 138,986,330 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding138,986,330
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Bio View’s return on equity (ROE) is -0.14 and return on invested capital (ROIC) is -11.74%.
Return on Equity (ROE)-0.14
Return on Assets (ROA)-0.09
Return on Invested Capital (ROIC)-11.74%
Return on Capital Employed (ROCE)-0.12
Revenue Per Employee777.42K
Profits Per Employee-86.58K
Employee Count33
Asset Turnover0.76
Inventory Turnover1.21
Valuation Ratios
The current PE Ratio of Bio View is ―. Bio View’s PEG ratio is 0.01.
PE Ratio―
PS Ratio1.55
PB Ratio1.73
Price to Fair Value1.73
Price to FCF-12.66
Price to Operating Cash Flow-4.02
PEG Ratio0.01
Income Statement
In the last 12 months, Bio View had revenue of 25.66M and earned -3.15M in profits. Earnings per share was -0.02.
Revenue25.66M
Gross Profit15.56M
Operating Income-2.88M
Pretax Income-2.86M
Net Income-3.15M
EBITDA-943.00K
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -5.66M and capital expenditures -81.00K, giving a free cash flow of -5.74M billion.
Operating Cash Flow-5.66M
Free Cash Flow-5.74M
Free Cash Flow per Share-0.04
Dividends & Yields
Bio View pays an annual dividend of 200, resulting in a dividend yield of ―
Dividend Per Share200
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.20
52-Week Price Change-45.66%
50-Day Moving Average20.79
200-Day Moving Average25.48
Relative Strength Index (RSI)50.95
Average Volume (3m)143.53K
Important Dates
Bio View upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend DateMar 22, 2017
Financial Position
Bio View as a current ratio of 2.51, with Debt / Equity ratio of 9.33%
Current Ratio2.51
Quick Ratio1.65
Debt to Market Cap0.04
Net Debt to EBITDA6.61
Interest Coverage Ratio-7.71
Taxes
In the past 12 months, Bio View has paid 291.00K in taxes.
Income Tax291.00K
Effective Tax Rate-0.10
Enterprise Valuation
Bio View EV to EBITDA ratio is -35.57, with an EV/FCF ratio of -10.68.
EV to Sales1.31
EV to EBITDA-35.57
EV to Free Cash Flow-10.68
EV to Operating Cash Flow-10.80
Balance Sheet
Bio View has 7.84M in cash and marketable securities with 1.86M in debt, giving a net cash position of 5.98M billion.
Cash & Marketable Securities7.84M
Total Debt1.86M
Net Cash5.98M
Net Cash Per Share0.04
Tangible Book Value Per Share0.16
Margins
Gross margin is 46.36%, with operating margin of -11.21%, and net profit margin of -12.27%.
Gross Margin46.36%
Operating Margin-11.21%
Pretax Margin-11.14%
Net Profit Margin-12.27%
EBITDA Margin-3.68%
EBIT Margin-10.30%
Analyst Forecast
The average price target for Bio View is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―